Digitalizing biopharma: How raw material data can maximize biopharma supply chain and manufacturing practices

Register & watch

As the transformation of biopharmaceutical manufacturing continues to evolve, biopharmaceutical manufacturers and raw material suppliers are entering the frontier of “biopharma 4.0” where AI, big data and smart systems are being leveraged to help transform the business model.

From incoming good receipts and raw material testing, to process development, manufacturing troubleshooting and predictive analytics targeting consistent and predictable biomanufacturing, data exchange programs with raw material manufacturers can have an immediate impact in the journey of creating a digital biomanufacturing process that reduces cost and improves productivity.

This presentation was given as part of BPI Spring Digital Week, Monday, 22nd June, 2020.

Register & watch

Presented by:

Claudia Berrón

Senior Vice President, Clinical Services

Claudia Berrón is Avantor’s Senior Vice President, Clinical Services. Prior to this, she was Senior Vice President, Business Development and Commercial Operations for our Biopharma Production business unit. Claudia has over two decades of experience in strategic marketing, covering ideation, value proposition strategies, market segmentation and planning through product and services launch into market. She has been with Avantor since 2015.

Claudia holds an MBA from the University of North Carolina Kenan-Flagler Business School and a bachelor’s degree from Monterrey Institute of Technology in Mexico City.

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.